Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients.
暂无分享,去创建一个
T K Lewellen | M. Graham | T. Lewellen | K. Krohn | J. Rasey | L. Peterson | W. Koh | W J Koh | J S Rasey | M L Evans | M M Graham | K A Krohn | M. L. Evans | L M Peterson | M. L. Evans
[1] R. Schimke,et al. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Chapman,et al. The detection and measurement of hypoxic cells in solid tumors , 1984, Cancer.
[3] K. Krohn,et al. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. , 1987, Radiation research.
[4] Thomas K. Lewellen,et al. Performance measurements of the SP3000/UW time-of-flight positron emission tomograph , 1988 .
[5] C. Coleman,et al. Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity. , 1988, Journal of the National Cancer Institute.
[6] S. Keyes,et al. Preclinical studies of porfiromycin as an adjunct to radiotherapy. , 1988, Radiation research.
[7] D. Stoler,et al. Normal fibroblasts responding to anoxia exhibit features of the malignant phenotype. , 1989, The Journal of biological chemistry.
[8] M. Graham,et al. High-speed automated discrete blood sampling for positron emission tomography. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] P. Vaupel,et al. Tumor tissue oxygenation as evaluated by computerized-pO2-histography. , 1990, International journal of radiation oncology, biology, physics.
[10] P Okunieff,et al. Correlations between 31P-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma. , 1989, Radiation research.
[11] Jean Charles Gilbert,et al. Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] J. D. Chapman,et al. Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] G L Rosner,et al. Pretreatment oxygenation profiles of human soft tissue sarcomas. , 1994, International journal of radiation oncology, biology, physics.
[14] R. Schimke,et al. Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (adriamycin) resistance. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[15] B. Fenton,et al. Cryospectrophotometric determination of tumor intravascular oxyhemoglobin saturations: dependence on vascular geometry and tumor growth. , 1988, Journal of the National Cancer Institute.
[16] T W Griffin,et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. , 1992, International journal of radiation oncology, biology, physics.
[17] P. Lambin,et al. Oxygenation of head and neck tumors , 1993, Cancer.
[18] M. Parliament,et al. Imaging tumor hypoxia and tumor perfusion. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] T. Lewellen,et al. Improving the performance of the SP-3000 PET detector modules , 1991, Conference Record of the 1991 IEEE Nuclear Science Symposium and Medical Imaging Conference.
[20] P Kolstad,et al. Intercapillary distance, oxygen tension and local recurrence in cervix cancer. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[21] David E. Housman,et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.
[22] S. Rockwell. Effect of some proliferative and environmental factors on the toxicity of mitomycin C to tumor cells in vitro , 1986, International journal of cancer.
[23] K. Krohn,et al. Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia. , 1989, International journal of radiation oncology, biology, physics.
[24] R. Hill,et al. Effects of reoxygenation on cells from hypoxic regions of solid tumors: analysis of transplanted murine tumors for evidence of DNA overreplication. , 1990, Cancer research.
[25] P. Workman,et al. Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. , 1994, International journal of radiation oncology, biology, physics.
[26] M. Graham,et al. A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data. , 1995, Medical physics.
[27] I. Stratford,et al. The effect of hypoxia on acquired drug resistance and response to epidermal growth factor in chinese hamster lung fibroblasts and human breast‐cancer cells in vitro , 1993, International journal of cancer.
[28] R E Durand,et al. Detection of hypoxic cells in a murine tumor with the use of the comet assay. , 1992, Journal of the National Cancer Institute.
[29] J. Rasey,et al. Characteristics of the binding of labeled fluoromisonidazole in cells in vitro. , 1990, Radiation research.
[30] P Vaupel,et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[31] M. Höckel,et al. Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. , 1993, Gynecologic oncology.
[32] C. Mathis,et al. A radiosynthesis of fluorine-18 fluoromisonidazole. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[33] R. Gatenby,et al. Oxygen tension in human tumors: in vivo mapping using CT-guided probes. , 1985, Radiology.
[34] P. Hahnfeldt,et al. Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. , 1994, Cancer research.
[35] T. Kwok,et al. Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance. , 1991, British Journal of Cancer.
[36] C. Koch,et al. Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. , 1990, Biochemical pharmacology.
[37] B. Teicher,et al. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. , 1981, Cancer research.
[38] I. Tannock,et al. Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines. , 1990, Journal of the National Cancer Institute.
[39] L. M. Cobb,et al. Tissue distribution of 14C- and 3H-labelled misonidazole in the tumor-bearing mouse. , 1990, International journal of radiation oncology, biology, physics.
[40] P Vaupel,et al. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. , 1991, Cancer research.
[41] K L Lindsley,et al. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. , 1995, International journal of radiation oncology, biology, physics.
[42] R. Hill,et al. Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. , 1990, Journal of the National Cancer Institute.
[43] R. Gatenby,et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. , 1988, International journal of radiation oncology, biology, physics.
[44] L. Golberg,et al. Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study. , 1992, British Journal of Cancer.